In conclusion, this study provides evidence that diacerein reverses the pro-atherogenic and pro-inflammatory gene regulation caused by IL-1 in ECs and KCs, potentially preventing progression of skin inflammation and inflammation-induced atherosclerosis. The gene discussed is IL1B; the disease is atherosclerosis.